SANKYO C23 Pill - yellow oval, 15mm
Generic Name: hydrochlorothiazide/olmesartan
Pill with imprint SANKYO C23 is Yellow, Oval and has been identified as Benicar HCT 12.5 mg / 40 mg. It is supplied by Sankyo Pharma.
Benicar HCT is used in the treatment of High Blood Pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Benicar HCT 12.5 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SANKYO C23
Benicar HCT
- Generic Name
- hydrochlorothiazide/olmesartan
- Imprint
- SANKYO C23
- Strength
- 12.5 mg / 40 mg
- Color
- Yellow
- Size
- 15.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Angiotensin II inhibitors with thiazides
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sankyo Pharma
- Inactive Ingredients
-
hydroxypropyl cellulose,
hypromelloses,
lactose monohydrate,
low substituted hydroxypropyl cellulose,
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
65597-0106 (Discontinued) | Daiichi Sankyo Inc. |
57664-0759 | Caraco Pharmaceutical Laboratories, Ltd. |
35356-0288 | Lake Erie Medical and Surgical Supply (repackager) |
54868-5075 (Discontinued) | Physicians Total Care Inc. (repackager) |
54569-5998 | A-S Medication Solutions, LLC (repackager) |
35356-0257 (Discontinued) | Lake Erie Medical and Surgical Supply (repackager) |
Related images for "SANKYO C23"
More about Benicar HCT (hydrochlorothiazide / olmesartan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (29)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: angiotensin II inhibitors with thiazides
- En español
Patient resources
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.